In vitro susceptibility patterns for slowly growing non-tuberculous mycobacteria in the USA from 2018 to 2022

Abstract excerpt

BACKGROUND: Treatment of slowly growing non-tuberculous mycobacteria (SGM) is challenging. In vitro antimicrobial susceptibility testing (AST) is needed to optimize a multidrug regimen but requires weeks to result. Aggregated AST patterns, or an antibiogram, of SGM would be helpful to providers. OBJECTIVES: We aggregated and analysed human SGM isolates sent to our laboratory from across the USA between 2018 and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Actinomycetales infections and treatment
• Share to Mycobacterium research and diagnosis
• Share to Tuberculosis Research and Epidemiology